Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options

Neurobiology of Aging

Volumn 17, Issue 5, 1996, Pages 795-800

  Hull M ^a   Fiebich, B L ^a   Lieb, K ^a   Strauss, S ^a   Berger, M ^a   Volk, B ^a   Bauer, J ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; Interleukin 6; Nonsteroidal antiinflammatory drugs (NSAIDs); Primitive plaques; Senile plaques

Indexed keywords

INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; TENIDAP;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0030250558     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00107-8     Document Type: Article

References (60)

1. 1. Abraham, C. R.; Selkoe, D. J.; Potter, H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501: 1988.
2. 2. Andus, T.; Bauer, J.: Gerok, W. Effects of cytokines on the liver. J Neurochem. 63:2225-2230; 1995.
3. 3. Bauer, J. Interleukin-6 and its receptor during homeostasis, inflammation and tumor growth. Klin. Wochenschr. 67:697-706; 1989.
4. 4. Bauer, J.; Ganter, U.; Abel, J.; Strauss, S.; Jonas. U.; Weiss, R.; Gebicke-Haerter, P.; Volk, B.; Berger, M. Effects of interleukin 1 and interleukin 6 on metallothionin and amyloid precursor protein expression in human neuroblastoma cells. J. Neurol. Immunol. 45:163-173; 1993.
5. 5. Bauer, J.; Herrmann, F. Interleukin-6 in clinical medicine. Ann. Hematol. 62:203-213; 1991.
6. 6. Bauer, J.; Stadtmüller, G.; Qualmann. J.; Bauer, H. Premorbid psychological processes in Alzheimer's disease and in vascular dementia. Z. Gerontol. Geriatr. 28:179-189; 1995.
7. 2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices. FEBS Lett. 285:111-114; 1991.
8. 8. Baumann, H.; Gauldie, J. The acute phase response. Immunol. Today 15:74-80; 1994.
9. 9. Berg, L.; McKeel, D. W. J.; Miller, J. P.; Baty, J.; Morris, J. C. Neuropathological indexes of Alzheimer's disease in demented and non-demented persons aged 80 years and older. Arch. Neurol. 50:349-358; 1993.
10. 10. Beyreuther, K.; Pollwein, P.; Multhaup, G.; Monning, U.; Konig, G.; Dyrks, T.; Schubert, W.; Masters, C. L. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann. NY Acad. Sci. 695:91-102; 1993.
11. 11. Braak, H.; Braak. E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82:239-259; 1991.
12. 12. Braak, H.; Braak, E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16:271-278; 1995.
13. 13. Breitner, J. C. S.; Gau, B. A.: Welsh, K. A.; Plassmann, B. L.; McDonald, W. M.; Helms, M. J.; Anthony, J. C. Inverse association of antiinflammatory treatments and Alzheimer's disease: Intial results of a co-twin control study. Neurology 44:227-232; 1994.
14. 14. Brugg, B.; Dubreuil, Y. L.; Huber, G.; Wollman, E. E.; Delhaye-Bouchaud, N.; Mariani, J. Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. USA 92:3032-3035; 1995.
15. 15. Campbell, I. L.; Abraham, C. R.; Masliah, E.; Kemper, P.; Inglis, J. D.; Oldstone, M. B. A.: Mucke, E. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90:10061-10065; 1993.
16. 16. Daynes, R. A.; Araneo, B. A.; Ershler, W. B.; Maloney, C.; Li, G.-Z.; Ryu, S.-Y. Altered regulation of IL-6 production with normal aging. J. Immunol. 150:5219-5230; 1993.
17. 17. DeKosky, S. T.; Scheff, S. W. Synapse loss in frontal cortex biopsies in Alzheitner's disease: Correlation with cognitive seventy. Ann. Neurol. 27:457-464; 1990.
18. 18. Del Bo, R.; Angeretti, N.; Lucca, E.; Grazia De Simoni, M.; Forloni, G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures. Neurosci. Lett. 188:70-74; 1995.
19. 19. Delaere, P.; Duyckaerts, C.; He, Y.; Piette, F.; Hauw, J. J. Subtypes and differential laminar distributions of beta A4 deposits in Alzheimers disease: Relationship with the intellectual status of 26 cases. Acta Neuropathol. (Berl.) 81:328-335; 1991.
20. 20. DeRijk, R. H.; Boelen, A.; Tilders, F. J. H.; Berkenbosch, F. Induction of plasma interleukin-6 by circulating adrenalin in rat. Psychoneuroendocrinology 19:155-163; 1994.
21. 21. Dickson, D. W.; Eee, S. C.; Mattiace, L. A.; Yen, S. C.; Brosnan, C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83; 1993.
22. 22. Dickson, D. W.; Mattiace, L. A.; Kure, K.; Hutchins, K.; Lyman, W. D.; Brosnan, C. F. Microglia in human disease, with an emphasis on acquired immune deficiency syndrom. Lab. Invest. 64:135-156; 1991.
23. 23. Ershler, W. B. Interleukin-6: A cytokine for gerontologists. J. Am. Geriatr. Soc. 41:176-181; 1993.
24. 24. Fischer, B.; Schmoll, H.; Riederer, P.; Bauer, J.; Platt, D.; PopaWagner, A. Complement C1q and C3 niRNA expression in the frontal cortex of Alzheimer's patients. J. Mol. Med. 73:465-471; 1995
25. 25. Gilad, G. M.; Gilad, V. H. Strain, stress, neurodegeneration and longevity. Mech. Age Dev. 78:75-83; 1995.
26. 26. Gottschall, P. E.; Tatsuno, I Arimura, A. Regulation of interleukin 6 (IL-6) secretion in primary cultured rat astrocytes: Synergism of interleukin 1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res. 637:197-203; 1994.
27. 27. Griffin, W. S. T.; Sheng, J. G.; Roberts. G. W.; Mrak, R. E. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54: 276-281; 1995.
28. 28. Griffin, W. S. T.; Stanley, L. C.; Eing, C.; White, E.; MacLeod, V.; Perrot, L. J.; White, C. E.; Araoz, C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrom and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7611-7615; 1989.
29. 29. Hager. K.; Machein, U.; Krieger, S.; Seefried, G.; Bauer, J. Plasma concentrations of interleukin-6 and selected plasma proteins in healthy-persons of different ages. Neurobiol. Aging 15:771-772; 1994.
30. 30. Halliday, G.; Flowers, D.; Baum, E. Analysis of staining methods for different cortical plaques in Alzheimer's disease. Acta Neuropathol. (Berl.) 87:174-188; 1994.
31. 31. Higuchi, M.; Ho, T.; Iwaki, T.; Hattori, M.; Kohsaka, S.; Niho, Y.; Sakaki, Y. Expression of the alpha-2-macroglobtilin-encoding gene in rat brain and cultured astrocytes. Gene 141:155-162; 1994.
32. 32. Huell, M.; Strauss. S.; Volk, B.; Berger, M.; Bauer, J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol. (Berl.) 89: 544-551; 1995.
33. 33. Itagaki, S.; Akiyama, H.; Saito, H.; McGeer, P. L. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease. Brain Res. 645:78-84; 1994.
34. 34. Jellinger, K.; Bancher, C.; Fischer. P.; Lassmann. H. Quantitative histopathologic validation of senile dementia of the Alzheimer type. Eur. J. Gerontol. 3:146-156; 1992.
35. 35. Khachaturian, Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1097-1104; 1985.
36. 36. Ladror, U. S.; Kohnken, R. E.; Wang, G. T.; Manelli. A. M.; Frail, D. E.; Klein, W. L.; Holzman, T. F.; Krafft, G. A. Evidence against a role for the Kunitz domain in amyloidogenic and secretory processing of the amyloid precursor protein. J. Neurochem. 63:2225-2230; 1994.
37. 37. Madhok, R. Tenidap. Lancet 346:481-485, 1995.
38. 38. LeMay, L. G.; Vander. A. J.; Kluger, M. J. The effect of psychological stress on plasma interleukin-6 activity in rats. Physio). Behav. 47:957-961; 1990.
39. 39. Maeda, Y.; Matsumoto, M.; Hori, Ov, Kuwabara, K.; Ogawa, S.; Yan, S. D.; Ohtsuki, T.; Kinoshita, T.; Kamada, T.; Stern, D. M. Hypoxia/ Reoxygenation-mediated induction of astrocyte interleukin 6: Paracrine mechanism, potentially enhancing neuron survival. J. Exp. Med. 180:2297-2308; 1994.
40. 40. Maimone, D.; Cioni, C.; Rosa, S.; Macchia, G.; Alois!, F.; Annunziata, P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1beta and TNFalpha. J. Neuroimmunol. 47:73-82: 1993.
41. 41. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer, E. G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107:341-346; 1989.
42. 42. McGeer, P. L.; Kawamata. T.; Walker, D. G.; Akiyama. H.; Tooyama, L; McGeer, E. G. Microglia in degenerative neurological disease. Glia 7:84-92; 1993.
43. 43. McGeer, P. L.; Klegeris, A.; Walker, D. G.; Yasuhara, O.; McGeer, E. G. Pathological proteins in senile plaques. Tohoku J. Exp. Med. 174:269-277; 1994.
44. 44. Minami, M.; Kuraishi, Y.; Satoh, M. Effects of kainic acid on mRNA levels of IL-1beta, IL-6, TNFalpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176:593-598; 1991.
45. 45. Morrow, L. E.; McClellan, J. L.; Conn, C. A.; Kluger, M. J. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am. J. Physiol. 264:R1010-R1016; 1993.
46. 46. Murphy, D. G. M.; Bottomley, P. A.; Salerno, J. A.; DeCarli, C.; Mentis, M. J.; Grady, C. L.; Teichberg, D.; Giacometti, K. R.; Rosenberg, J. M.; Hardy, C. J.; Schapiro, M. B.; Rapaport, S. I.; Alger, J. R.; Horwitz, B. An in vivo study of phosphorus and glucose metabolism in Alzheimer's Disease using magnetic resonance spectroscopy and PET. Arch. Gen. Psychiatry 50:341-349; 1993.
47. 47. Norris, J. G.; Benveniste, E. N. Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine, J. Neurol. Immunol. 45:137-146; 1993.
48. 48. Orrell, M. W.; O'Dwyer, A.-M. Dementia, ageing, and the stress control system. Lancet 345:666-667; 1995.
49. 49. Rich, J. B.; Rasmusson, D. X.; Folstein, M. F.; Carson, K. A.; Kawas, C.; Brandt, J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45:51-55; 1995.
50. 50. Rogers, J.; Kirby, L. C.; Hempelman, S. R.; Berry, D. L.; McGeer, P. L.; Kaszniak, A. W.; Zalinski, J.; Cofield, M.; Mansukhani, L.; Willson, P.; et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-1611; 1993.
51. 51. Rogers, J. Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneimittelforschung 45:439-442; 1995.
52. 52. Sparks, D. L.; Liu, H.; Scheff, S. W.; Coyne, C. M.; Hunsaker, J. C. Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J. Neuropathol. Exp. Neurol. 52:135-142; 1993.
53. 53. Stein, T. P.; Schluter, M. D. Excretion of Interleukin-6 by astronauts during spaceflight. Am. J. Physiol. 266:448-452; 1994.
54. 54. Strauss, S.; Bauer, J.; Ganter, U.; Jonas, U.; Berger, M.; Volk, B. Detection of interleukin 6 and alpha-2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66:223-230; 1992.
55. 55. Tanzi, R. E.; Wenniger, J. J.; Hyman, B. T. Cellular specificity and regional distribution of amyloid beta protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation. Brain Res. Mol. Brain Res. 18:246-252; 1993.
56. 56. Terry, R. D.; Masliah, E.; Salmon, D. P.; Butters, N.; DeTeresa, R.; Hill, R.; Hansen, L. A.; Katzman, R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:572-580; 1991.
57. 57. Wisniewski, H. M.; Terry, R. D. Reexamination of the pathogenesis of the senile plaque. Prog. Neuropathol. 2:1-26; 1973.
58. 58. Wood, J. A.; Wood, P. L.; Ryan, R.; Graff-Radford, N. R.; Pilapil, C.; Robitaille, Y.; Quirion, R. Cytokine indices in Alzheimer's temporal cortex: No changes in mature IL-1 beta or IL-1 RA but increases in the associated acute phase proteins IL-6, alpha-2-macroglobulin and C-reactive protein. Brain Res. 629:245-252; 1993.
59. 59. Yamamoto, T.; Hirano, A. A comparative study by modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol. Appl. Neurobiol. 12:3-9; 1986.
60. 60. Zhou, D.; Kusnecov, A. W.; Shurin, M. R.; DePaoli, M.; Rabin, B. S. Exposure to physical and psychological Stressors elevates plasma interleukin-6, relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133:2523-2530; 1993.